Thorne

THORNE HEALTHTECH'S ONEDRAW DEVICE USED IN DEPARTMENT OF DEFENSE'S CANCER MOONSHOT 2.0 PROJECT, PROMETHEUS, AS PART OF PRESIDENT BIDEN INITIATIVE

Retrieved on: 
Thursday, November 17, 2022
Cancer, CE marking, National Institute of Environmental Health Sciences, Diabetes, United States Department of Defense, Department of Defense Serum Repository, Partnership, FDA, Medication, Mayo Clinic, Education, Research, Thorne, Multimedia, Medicines and Healthcare products Regulatory Agency, National Toxicology Program, Uniformed Services University of the Health Sciences, Glycated hemoglobin, Outline of health sciences, PMDA, Blood, Division, USU, Association of British HealthTech Industries, Glucose, Engineering, Pharmaceuticals and Medical Devices Agency, White House, Sabotage (2014 film), Pharmaceutical industry, Medical device, Dietary supplement, Health, Defense

"As health and wellness continues to evolve and demands for reliable and convenient testing grow, our OneDraw device showcases that next-gen multi-omics testing can be performed on patient-friendly platforms," said Paul Jacobson, CEO of Thorne HealthTech.

Key Points: 
  • "As health and wellness continues to evolve and demands for reliable and convenient testing grow, our OneDraw device showcases that next-gen multi-omics testing can be performed on patient-friendly platforms," said Paul Jacobson, CEO of Thorne HealthTech.
  • "At Thorne HealthTech, we believe in the power of scientific wellness and taking a preventative approach to health and wellness, which is exactly what President Biden's Cancer Moonshot Project is doing with our OneDraw device."
  • This research is critical to developing new tools for the early detection and possible prevention of cancer."
  • Arising out of President Biden's White House Cancer Moonshot 2.0 initiative in 2022, PROMETHEUS is a project of the Department of Defense's Uniformed Services University of the Health Sciences (USU) Murtha Cancer Center Research Program (MCCRP).

Thorne HealthTech Announces Second Quarter 2022 Earnings Release Date and Conference Call

Retrieved on: 
Tuesday, July 19, 2022
Multimedia, NASDAQ, Thorne, Mayo Clinic, Association of British HealthTech Industries, Research, International, Education, Solution, Health, Video game

NEW YORK, July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, will release its second quarter 2022 financial results after the market close on Tuesday.

Key Points: 
  • NEW YORK, July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, will release its second quarter 2022 financial results after the market close on Tuesday.
  • The company will host a conference call on Wednesday, Aug. 10, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its second quarter 2022 financial results.
  • A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com .
  • Thorne HealthTech is a leader in developing innovative solutions for delivering personalized approaches to health and wellness.

Thorne HealthTech Announces First Quarter 2022 Earnings Release Date and Conference Call

Retrieved on: 
Friday, April 22, 2022
NASDAQ, Research, International, Multimedia, Mayo Clinic, Health, Education, Solution, Thorne, Association of British HealthTech Industries, Video game

NEW YORK, April 22, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will release its first quarter 2022 financial results after the market close on Wednesday, May 11, 2022.

Key Points: 
  • NEW YORK, April 22, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will release its first quarter 2022 financial results after the market close on Wednesday, May 11, 2022.
  • The company will host a conference call on Thursday, May 12, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its first quarter 2022 financial results.
  • A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com .
  • Thorne HealthTech is a leader in developing innovative solutions for delivering personalized approaches to health and well-being.

Thorne HealthTech Announces Fourth Quarter and Full-Year 2021 Earnings Conference Call

Retrieved on: 
Friday, February 25, 2022
NASDAQ, Health, Association of British HealthTech Industries, Solution, International, Thorne, Pharmaceutical industry

NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will host a conference call on Tuesday, March 15, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2021 financial results.

Key Points: 
  • NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will host a conference call on Tuesday, March 15, 2022, at 8 a.m. (U.S. Eastern Time) to discuss its fourth quarter and full-year 2021 financial results.
  • A live webcast of the call can be accessed by logging onto the investors section of the Thorne HealthTech website at https://investors.thornehealthtech.com .
  • Thorne HealthTech is a leader in developing innovative solutions for a personalized approach to health and wellbeing.
  • Thorne HealthTech is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals, and corporations.

Thorne HealthTech's First-of-Its-Kind 'Wellth Report' Reveals Shifts in Individuals' Health Behaviors with Ripple Effects for the Healthcare Industry and Broader Workforce

Retrieved on: 
Thursday, December 16, 2021
Anxiety, Solution, Sleep, Thorne, Millennials, Woman, Income, COVID-19, Time, INC, NASDAQ, CEO, Quality of life, Mental health, Association of British HealthTech Industries, Partnership, EST, Health, Pharmaceutical industry, Medicine, Intelligence

However, there is momentum building among adults, particularly millennials, toward adopting new solutions to improve their health.

Key Points: 
  • However, there is momentum building among adults, particularly millennials, toward adopting new solutions to improve their health.
  • "At Thorne HealthTech, we've long believed in a future-focused approach to health," said CEO of Onegevity, a Thorne HealthTech division, Dr. Nathan Price.
  • The Wellth Report makes clear that many are experiencing burn-out and exhaustion, and that taking back control starts with prevention."
  • Despite the strong desire to lead a healthier lifestyle, sleep quality and mental health remain major challenges for adults.

Thorne HealthTech to Host Third Quarter 2021 Earnings Conference Call

Retrieved on: 
Monday, October 25, 2021
Solution, Health, Thorne, Telephone, NASDAQ, Investor, Association of British HealthTech Industries

NEW YORK, Oct. 25, 2021 /PRNewswire/ --Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will release third quarter 2021 financial results on Wednesday, November 10, 2021, prior to the market open.

Key Points: 
  • NEW YORK, Oct. 25, 2021 /PRNewswire/ --Thorne HealthTech, Inc. (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, will release third quarter 2021 financial results on Wednesday, November 10, 2021, prior to the market open.
  • In conjunction with the earnings release, Thorne HealthTech's management team will host a conference call at 8:30 a.m.
  • To listen to the live webcast, please visit the Investors section of the Thorne HealthTech website at: http://investors.thornehealthtech.com .
  • The webcast replay will be available on the Thorne HealthTech website for one year following completion of the call.

Hamilton Thorne Announces the Increase of Its Bank Lines of Credit to US$12.5 Million

Retrieved on: 
Tuesday, July 27, 2021
Alexander Hamilton, BNY Mellon, Thorne, United States, Philosophers

In addition, its bank has agreed to renew and expand its acquisition line of credit to US$8 million to support growth and future acquisitions, and to extend its US$4.5 million bank operating line of credit for an additional year to July 2023.

Key Points: 
  • In addition, its bank has agreed to renew and expand its acquisition line of credit to US$8 million to support growth and future acquisitions, and to extend its US$4.5 million bank operating line of credit for an additional year to July 2023.
  • Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets.
  • Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event brands, through its growing sales force and distributors worldwide.
  • This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict.

Hamilton Thorne Announces the Acquisition of IVFTECH ApS and K4 Technology ApS

Retrieved on: 
Thursday, July 15, 2021
Thorne

and TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) research, and cell biology markets, today announced that it has completed the acquisition (the "Transaction") of IVFTECH ApS ("IVFtech") and its affiliated reseller arm, K4 Technology ApS ("K4").

Key Points: 
  • and TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) research, and cell biology markets, today announced that it has completed the acquisition (the "Transaction") of IVFTECH ApS ("IVFtech") and its affiliated reseller arm, K4 Technology ApS ("K4").
  • Kjeld Nielsen, Founder of IVFtech commented, "The entire IVFtech team is extremely pleased to be joining Hamilton Thorne who shares our belief in quality and service.
  • We believe that the combination of the businesses can significantly accelerate the growth of both the Hamilton Thorne and IVFtech operations around the world.
  • Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event brands, through its growing sales force and distributors worldwide.

Thorne and Effusio Sponsor World Champion Surfer, John John Florence

Retrieved on: 
Tuesday, June 8, 2021
Thorne

Florence will serve as a brand ambassador for Thorne and Effusio, a health solutions company that partners with Thorne and leverages proprietary printing technology to provide healthier alternatives to traditional beverages.

Key Points: 
  • Florence will serve as a brand ambassador for Thorne and Effusio, a health solutions company that partners with Thorne and leverages proprietary printing technology to provide healthier alternatives to traditional beverages.
  • "John John's voice, coupled with support from Effusio, will be impactful for not only all surfing fans but also those searching for globally supportive solutions in health and wellness."
  • I'm looking forward to exploring which supplements work best for me throughout my various activities," said Florence.
  • The multi-year sponsorship also offers Florence potential collaborative product development opportunities with Effusio and Thorne.

Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2021

Retrieved on: 
Tuesday, May 25, 2021
Thorne

Tek-Event is also a value-added reseller of a select range of capital equipment and consumables, including those manufactured by Hamilton Thorne.

Key Points: 
  • Tek-Event is also a value-added reseller of a select range of capital equipment and consumables, including those manufactured by Hamilton Thorne.
  • The Company has scheduled a conference call on Tuesday, May 25, 2021 at 11:00 a.m. EDT to review highlights of the results.
  • Financial statements and accompanying Management Discussion and Analysis for the periods are available on www.sedar.com and the Hamilton Thorne website.
  • Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, Embryotech Laboratories, and Tek-Event brands, through its growing sales force and distributors worldwide.